Glycolysis Inhibitors as Potential Cancer Therapeutics
Application
A new potential anti-cancer agent that inhibits the glycolytic enzyme PGAM1 and thereby tumor growth.
Key Benefits
Targets tumor metabolism by inhibiting glycolytic enzyme and turning off tumor metabolism.
Inhibition of glycolytic enzyme (PGAM1) by these inhibitors leads to significant reduction in tumor growth.
Market Summary
There...
Published: 8/30/2023
Contributor(s): Jing Chen, Taro Hitosugi, Sumin Kang
|